Economic impact of antimicrobial resistance.

• Authors: John E McGowan Jr., Emory University
• Journal Title: Emerging Infectious Diseases
• Volume: Volume 7, Number 2
• Publisher: U.S. National Center for Infectious Diseases | 2001-03, Pages 286-292
• Type of Work: Article | Final Publisher PDF
• Subjects: Health Sciences, Epidemiology; Health Sciences, Health Care Management

Abstract

One reason antimicrobial-drug resistance is of concern is its economic impact on physicians, patients, health-care administrators, pharmaceutical producers, and the public. Measurement of cost and economic impact of programs to minimize antimicrobial-drug resistance is imprecise and incomplete. Studies to describe and evaluate the problem will have to employ new methods and be of large scale to produce information that is broadly applicable.